Riad Elmor

Clinical Use of Tecovirimat (Tpoxx) for Treatment of Monkeypox Under an Investigational New Drug Protocol — United States, May–August 2022

Kevin O’Laughlin, Farrell A. Tobolowsky, Riad Elmor et al. · MMWR Morbidity and Mortality Weekly Report · 2022 · 139 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +9

The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study

Frank R. Ernst, Peri Barr, Riad Elmor et al. · Clinical Drug Investigation · 2016 · 52 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +15

Tecovirimat Use under Expanded Access to Treat Mpox in the United States, 2022–2023

Patricia Yu, Riad Elmor, Kalimah Muhammad et al. · NEJM Evidence · 2024 · 37 citations · Full text

Veterinary Medicine, Infectious Diseases, Pharmacotherapy +4

Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study

Frank R. Ernst, Walter Sandulli, Riad Elmor et al. · Drugs in R&D · 2016 · 23 citations · Full text

Pharmacy, Endocrinology, Pharmacotherapy +13

Relapse outcomes, safety, and treatment patterns in patients diagnosed with relapsing-remitting multiple sclerosis and initiated on subcutaneous interferon<i>β</i>-1a or dimethyl fumarate: a real-world study

Frank R. Ernst, Peri Barr, Riad Elmor et al. · Current Medical Research and Opinion · 2017 · 13 citations

Medicine, Immunology, Neurology +17